New Haven-based biotech company to add jobs as it partners on cancer drug
Cybrexa Therapeutics to add employees and as much as $700m in fees as it works to develop a new drug with a California company |!| New Haven
Cybrexa Therapeutics to add employees and as much as $700m in fees as it works to develop a new drug with a California company |!| New Haven